AMENDMENT NO. 1 TO AMENDED AND RESTATED CANCER LICENSE AGREEMENTCancer License Agreement • May 6th, 2021 • Syros Pharmaceuticals, Inc. • Pharmaceutical preparations • California
This Amendment to Amended and Restated License Agreement (this “Amendment”) is made as of January 8, 2021 by and between Syros Pharmaceuticals, Inc., a Delaware corporation having a place of business at 35 CambridgePark Drive, 4th Floor, Cambridge, Massachusetts 02140 USA (“Syros”) TMRC Co., Ltd., a Japanese corporation having a place of business at 1-12-12, Kita Shinjuku, Shinjuku-ku, Tokyo 164-0074, Japan (“TMRC”).
